The Medical Letter on Drugs and Therapeutics
- A Sumatriptan Patch (Zecuity) for Migraine
- Two Long-Acting Injectable Antipsychotics for Schizophrenia
- Budesonide Rectal Foam (Uceris) for Ulcerative Colitis
- Transdermal Fentanyl (Ionsys) for Postoperative Pain
- In Brief: Hepatic Injury with Hepatitis C Drugs
- Addendum: Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder
A Sumatriptan Patch (Zecuity) for Migraine
November 9, 2015 (Issue: 1481)The FDA has approved a sumatriptan iontophoretic transdermal system (Zecuity – Teva) for acute treatment of migraine in adults. Sumatriptan, the first of seven serotonin receptor antagonists (triptans) approved for this indication, is the most...more
- Drugs for migraine. Treat Guidel Med Lett 2013; 11:107.
- M Vikelis et al. Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine. Neuropsychiatr Dis Treat 2012; 8:429.
- MW Pierce. Transdermal delivery of sumatriptan for the treatment of acute migraine. Neurotherapeutics 2010; 7:159.
- J Goldstein et al. A sumatriptan iontophoretic transdermal system for the acute treatment of migraine. Headache 2012; 52:1402.
- TR Smith et al. Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system. Headache 2012; 52:612.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.